Editorial
Evidence-based standardized diagnosis and treatment of small gastrointestinal stromal tumors
Ye Yingjiang, Wang Chao
Published 2020-09-25
Cite as Chin J Gastrointest Surg, 2020, 23(9): 835-839. DOI: 10.3760/cma.j.cn.441530-20200807-00463
Abstract
The actual incidence of small gastrointestinal stromal tumors (GIST) increases gradually. Although the biological behavior of most of small GIST is benign or indolent, a few small GIST can develope to recurrence and metastasis with biological invasive behavior. Identification of biological behavior and malignant potential is the cornerstone of treatment. For non-gastric small GIST, surgery is always the treatment of choice. Regarding gastric small GIST, close follow-up is acceptable for patients without risk factors detected by endoscopic ultrasonography. Surgery should be suggested for those with high risks, or significant growth of tumor during follow-up. Complete resection with function preservation is the principle of surgery. Besides, individualized treatment should also be taken into consideration.
Key words:
Gastrointestinal stromal tumor, small; Diagnosis; Treatment; Evidence-based medicine
Contributor Information
Ye Yingjiang
Department of Gastrointestinal Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China
Wang Chao
Department of Gastrointestinal Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China